Floatz logo

11 assets in Cerebral Atherosclerosis

Therapeutic assets addressing Cerebral Atherosclerosis, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Atorvastatin
Cerebral Atherosclerosis
General Hospital of Shenyang Military RegionP4BB (65)
Immunoglobulin G1 (256-Tyrosine,258-Threonine,260-Glutamic Acid), Anti-(Neural Apoptosis-Regulated Proteinase 1) (Human-Mus Musculus Monoclonal Hrp00130 .Gamma.1-Chain), Disulfide With (3-Valine,5-Serine,49-Serine,66-Aspartic Acid) Human-Mus Musculus Monoclonal Hrp00130 .Kappa.-Chain, Dimer
Cerebral Atherosclerosis
Peking Union Medical College HospitalP4BB (65)
Probucol
Cerebral Atherosclerosis
General Hospital of Shenyang Military RegionP4BB (65)
Rucacuzumab
Cerebral Atherosclerosis
Peking Union Medical College HospitalP4BB (65)
Aspirin
Cerebral Atherosclerosis
Population Health Research InstituteP3BB (64)
Rivaroxaban
Cerebral Atherosclerosis
Population Health Research InstituteP3BB (64)
Alirocumab
Cerebral Atherosclerosis
Chang Gung Memorial HospitalP2B (59)
Clopidogrel
Cerebral Atherosclerosis
The First Affiliated Hospital with Nanjing Medical UniversityP2/3B (57)
Dulaglutide
Cerebral Atherosclerosis
National University of SingaporeP2/3B (57)
3-N-BUTYLPHTHALIDE
Cerebral Atherosclerosis
First Affiliated Hospital, Sun Yat-Sen UniversityN/AD (30)